Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSanofi Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | $0.87 | $0.92 | $0.90 |
| Q2 2026 | 4 | $0.89 | $1.56 | $1.02 |
| Q3 2026 | 3 | $1.26 | $1.54 | $1.43 |
Sanofi Earnings Date And Information
Sanofi last posted its earnings results on Thursday, April 23rd, 2026. The company reported $1.1 earnings per share for the quarter, topping analysts' consensus estimates of $1.06 by $0.04. The company had revenue of 11.24 B for the quarter and had revenue of 46.72 B for the year. Sanofi has generated $3 earnings per share over the last year ($3.2 diluted earnings per share) and currently has a price-to-earnings ratio of 8.68. Sanofi has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Sanofi Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/23/2026 | Q1 2026 | $1.06 | $0.67 | -0.39 | $10.17 B | $11.24 B |
| 01/29/2026 | Q4 2025 | $0.84 | -$1.48 | -2.32 | $11.50 B | $12.21 B |
| 10/24/2025 | Q3 2025 | $1.60 | $1.15 | -0.45 | $12.35 B | $13.17 B |
| 07/31/2025 | Q2 2025 | $0.96 | $1.60 | 0.64 | $9.49 B | $10.74 B |
| 03/31/2025 | Q1 2025 | N/A | $0.76 | N/A | $9.99 B | $10.61 B |
| 02/13/2025 | Q4 2024 | N/A | $0.35 | N/A | $10.77 B | $7.63 B |
| 09/30/2024 | Q3 2024 | N/A | $1.13 | N/A | $13.03 B | $14.16 B |
| 07/25/2024 | Q2 2024 | $0.86 | $0.45 | -0.41 | $10.81 B | $11.38 B |
| 03/30/2024 | Q1 2024 | N/A | $0.46 | N/A | $10.62 B | $9.73 B |
| 02/23/2024 | Q4 2023 | N/A | -$0.22 | N/A | N/A | $12.20 B |
| 09/29/2023 | Q3 2023 | N/A | $1.00 | N/A | N/A | $12.70 B |
| 06/29/2023 | Q2 2023 | N/A | $0.57 | N/A | N/A | $10.68 B |
| 03/30/2023 | Q1 2023 | N/A | $0.80 | N/A | N/A | $10.86 B |
| 12/31/2022 | Q4 2022 | N/A | $1.24 | N/A | N/A | $11.46 B |
| 09/30/2022 | Q3 2022 | N/A | $0.83 | N/A | N/A | $13.14 B |
| 06/30/2022 | Q2 2022 | N/A | $0.47 | N/A | N/A | $10.74 B |
| 03/31/2022 | Q1 2022 | N/A | $0.81 | N/A | N/A | $10.05 B |
| 12/31/2021 | Q4 2021 | N/A | $0.45 | N/A | N/A | $10.42 B |
| 09/30/2021 | Q3 2021 | N/A | $0.93 | N/A | N/A | $10.83 B |
| 06/30/2021 | Q2 2021 | N/A | $0.48 | N/A | N/A | $9.05 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sanofi Earnings: FAQ's
In the previous quarter, Sanofi (:SNY) reported $1.1 earnings per share (EPS) to beat the analysts' consensus estimate of $1.06 by $0.04.
The conference call for Sanofi's latest earnings report can be listened to online.
The conference call transcript for Sanofi's latest earnings report can be read online.
Sanofi (:SNY) has a recorded annual revenue of $46.72 B.
Sanofi (:SNY) has a recorded net income of $7.81 B.Sanofi has generated $3.2 earnings per share over the last four quarters.
Sanofi (:SNY) has a price-to-earnings ratio of 8.68 and price/earnings-to-growth ratio is -0.72.